Plexus (NASDAQ:PLXS) Releases Q3 Earnings Guidance
by The Cerbat Gem
The Cerbat Gem— Plexus (NASDAQ:PLXS – Get Free Report) issued an update on its third quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.22-1.37 for the period, compared to the consensus estimate of $1.09. The company issued revenue guidance of $960 million – $1 billion, compared to the consensus revenue estimate […]
The Cerbat Gem—Kforce (NASDAQ:KFRC) Releases Q2 Earnings Guidance. Kforce (NASDAQ:KFRC – Get Free Report) issued an update on its second quarter earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.68-0.76 for the period, compared to the consensus estimate of $0.76. The company issued revenue guidance of $352-360 million, compared to the consensus revenue estimate of $363.93 million. […]
The Cerbat Gem—Biogen (NASDAQ:BIIB) Releases FY24 Earnings Guidance. Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $15.00-16.00 for the period, compared to the consensus EPS estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue estimate of $9.47 billion. […]
The Cerbat Gem—ARM (NASDAQ:ARM) Releases Q1 2025 Earnings Guidance. ARM (NASDAQ:ARM – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.320-0.360 for the period, compared to the consensus estimate of 0.310. The company issued revenue guidance of $875.0 million-$925.0 million, compared to the consensus revenue estimate of […]